Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37103363> ?p ?o ?g. }

Showing items 1 to 100 of ±159 with 100 items per page.

Q37103363 description "2013 թվականի ապրիլի 10-ին հրատարակված գիտական հոդված" @default.
Q37103363 description "article científic" @default.
Q37103363 description "article scientifique" @default.
Q37103363 description "articolo scientifico" @default.
Q37103363 description "artigo científico" @default.
Q37103363 description "artículu científicu espublizáu en 2013" @default.
Q37103363 description "bilimsel makale" @default.
Q37103363 description "scientific article published on 10 April 2013" @default.
Q37103363 description "vedecký článok" @default.
Q37103363 description "vetenskaplig artikel" @default.
Q37103363 description "videnskabelig artikel" @default.
Q37103363 description "vědecký článek" @default.
Q37103363 description "wetenschappelijk artikel" @default.
Q37103363 description "wissenschaftlicher Artikel" @default.
Q37103363 description "наукова стаття, опублікована у квітні 2013" @default.
Q37103363 description "научни чланак" @default.
Q37103363 description "مقالة علمية نشرت في 10 أبريل 2013" @default.
Q37103363 name "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 name "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 name "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 type Item @default.
Q37103363 label "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 label "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 label "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 prefLabel "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 prefLabel "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 prefLabel "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 P1433 Q37103363-A886C951-368E-44B5-B9B2-7CB14B014096 @default.
Q37103363 P1476 Q37103363-5DB0B86D-0EF2-4EE6-8EA3-B68542A82F69 @default.
Q37103363 P2093 Q37103363-01A297CA-939B-4F3A-8EE1-21E32418F1FE @default.
Q37103363 P2093 Q37103363-1831B8D4-E9F3-41AE-B7D8-F8985AA4DD43 @default.
Q37103363 P2093 Q37103363-279A0602-C284-4B18-AF6F-20B5338D5E72 @default.
Q37103363 P2093 Q37103363-449D74BD-111A-4B1A-B080-EF263B7A80DB @default.
Q37103363 P2093 Q37103363-4C995A22-9C51-4573-AF77-361CCDC6896F @default.
Q37103363 P2093 Q37103363-6147799B-B5F2-4A27-B8E4-24F82FE6C878 @default.
Q37103363 P2093 Q37103363-82314C4E-AF9A-4C92-AFF5-7528C45CB339 @default.
Q37103363 P2093 Q37103363-8572F083-1534-4657-9EB4-B04F1E2F9CB8 @default.
Q37103363 P2093 Q37103363-8BD8168F-CFD8-436C-A96E-3F76EC171257 @default.
Q37103363 P2093 Q37103363-D667C4B5-EB85-4342-B66A-8DAE0A012518 @default.
Q37103363 P2093 Q37103363-EC1FB5BA-F20D-4BF4-A597-F1CFBCD75BB9 @default.
Q37103363 P2860 Q37103363-1704D046-960B-466D-9E68-4BB667B1CBB7 @default.
Q37103363 P2860 Q37103363-2494577B-C74F-404C-AC8F-789C0A652823 @default.
Q37103363 P2860 Q37103363-24D05946-31C8-4281-B226-9E1BC706DA43 @default.
Q37103363 P2860 Q37103363-2632B29D-4BAC-464C-940F-1F4071271AB4 @default.
Q37103363 P2860 Q37103363-27B3006B-1308-4501-A5E0-5813F505252E @default.
Q37103363 P2860 Q37103363-2EA19DD1-3A65-422B-9ED8-E03666DA28DC @default.
Q37103363 P2860 Q37103363-2F1B4232-10B6-4ADD-8AFD-845B1C76D912 @default.
Q37103363 P2860 Q37103363-306699D1-8B9B-401B-828F-2A80D83C8A92 @default.
Q37103363 P2860 Q37103363-34CA9999-EA47-4149-84BD-BB518AB938F0 @default.
Q37103363 P2860 Q37103363-350F3478-4090-4432-9C97-BE2A72324153 @default.
Q37103363 P2860 Q37103363-3B184FA8-0A8B-4246-A77D-953ADF27F95E @default.
Q37103363 P2860 Q37103363-3E5320A8-5EEC-4BB0-8A29-31365B78AC0B @default.
Q37103363 P2860 Q37103363-424DBFF7-E009-47C2-9737-94080783BA54 @default.
Q37103363 P2860 Q37103363-44741C09-11E2-42C0-809A-34C2F1CF17B6 @default.
Q37103363 P2860 Q37103363-460F0BDC-0D5E-4EF3-8EA6-8404BCE1EFD6 @default.
Q37103363 P2860 Q37103363-5837A2BF-8DE9-4764-82BC-0FF6F3C766DA @default.
Q37103363 P2860 Q37103363-65EFB1B0-2E9A-4D5B-93C8-E704349E8DE8 @default.
Q37103363 P2860 Q37103363-786E4FE1-C1FB-4FCC-A079-F8BBF34E5344 @default.
Q37103363 P2860 Q37103363-7D48CF11-55ED-4A79-856A-37D678390CFD @default.
Q37103363 P2860 Q37103363-98912C67-4C1F-4C22-89AE-D931145C6983 @default.
Q37103363 P2860 Q37103363-A0716D80-0318-4557-9106-774FF154138B @default.
Q37103363 P2860 Q37103363-A47A86D6-96A3-4568-ABF9-FCAEA09E65C7 @default.
Q37103363 P2860 Q37103363-ADBFD0A7-F6A9-40F2-BC08-A864B24700B8 @default.
Q37103363 P2860 Q37103363-AE0BF901-493E-4D43-8D62-A0DF19071E28 @default.
Q37103363 P2860 Q37103363-B34FBC28-DD7A-4074-AE62-A8C005B867E5 @default.
Q37103363 P2860 Q37103363-B571603F-35CF-4D68-9F50-B4AE891D900C @default.
Q37103363 P2860 Q37103363-BD79E146-F887-459F-B804-E97725278899 @default.
Q37103363 P2860 Q37103363-C630A4C4-A64D-4DCA-98BD-A262211A4FF3 @default.
Q37103363 P2860 Q37103363-CC69CBC4-6AE7-4D0A-B558-A562F95B4306 @default.
Q37103363 P2860 Q37103363-CC8C6A34-7DCA-4B45-A953-75397FDBF9A0 @default.
Q37103363 P2860 Q37103363-CF18BDD0-AE3F-4845-BBC4-66BCA3A46162 @default.
Q37103363 P2860 Q37103363-E546FD2A-60DB-4976-8A44-E53F47104C7F @default.
Q37103363 P2860 Q37103363-E7849452-539F-4E0B-827A-F8AF82AEF3C5 @default.
Q37103363 P2860 Q37103363-F3271940-5208-40B5-9BF6-F699B4979C67 @default.
Q37103363 P2860 Q37103363-F4025BF1-A474-4AF3-AC6A-311DBDAB1CFD @default.
Q37103363 P2860 Q37103363-F7C08627-8A18-4175-91B0-DB70A43BEACD @default.
Q37103363 P2860 Q37103363-FA701BCE-3C02-4C06-A027-76D69082581E @default.
Q37103363 P2860 Q37103363-FD97D558-2ABA-40D2-AE27-C30174B521F9 @default.
Q37103363 P2860 Q37103363-FFE5E70F-3A0A-4E78-96A3-656C722B8A3A @default.
Q37103363 P2888 Q37103363-751752C3-831C-4CCF-8AA1-4F7A64C9EC9D @default.
Q37103363 P304 Q37103363-D79175BF-B111-4E46-9C46-0E9949F1CBD5 @default.
Q37103363 P31 Q37103363-D008E435-D50E-422D-9E16-13219AACB1FE @default.
Q37103363 P356 Q37103363-0D901BFE-A4F4-4A4E-A2E6-668DA14432E8 @default.
Q37103363 P407 Q37103363-263A2306-1404-469B-B5E3-3D94906F2C74 @default.
Q37103363 P433 Q37103363-E473BDFD-F47A-4240-9C15-C128594E99E7 @default.
Q37103363 P478 Q37103363-F2DB5F73-9D61-4D8E-BFA8-3CB3CBC8F61F @default.
Q37103363 P50 Q37103363-20793FD6-FF43-439B-975F-068DBD94EDB1 @default.
Q37103363 P577 Q37103363-7C434C68-B2FE-4C29-82A4-8051DF5D4324 @default.
Q37103363 P698 Q37103363-ECA2B415-303C-4EBB-A1CF-6407139AAFCA @default.
Q37103363 P921 Q37103363-B59713CC-2534-44A2-8913-DD2D2304F23D @default.
Q37103363 P921 Q37103363-C2057E6A-C578-4D03-AC70-2406A58491FC @default.
Q37103363 P932 Q37103363-8BFFAA15-A7C3-489E-84C2-4A699FCD2A35 @default.
Q37103363 P356 NPP.2013.85 @default.
Q37103363 P698 23575741 @default.
Q37103363 P1433 Q2261280 @default.
Q37103363 P1476 "The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings" @default.
Q37103363 P2093 "Andrew H Miller" @default.
Q37103363 P2093 "Daniel S Graciaa" @default.
Q37103363 P2093 "David H Lawson" @default.
Q37103363 P2093 "Dominique Musselman" @default.